Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features
J Clin Oncol Goldstein et al 26:4063-4071, 2008
Publisher’s Note
The September 1, 2008, article by Goldstein et al, entitled, “Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features” (J Clin Oncol 26:4063-4071, 2008), was published online August 4, 2008, with errors.
The Running Head was given as:
“21-Gene Assay Compared With Adjuvant!”
While it should have been:
“21-Gene Assay Compared With Clinicopathologic Features”
In Figures 2, 3, 4(B & C), and 5(A), the term “Adjuvant!” was used, whereas it should have been “Integrator.”
All corrections have been made as of July 2, 2009.
|
